FORMULATION OF FUSION PROTEIN INCLUDING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR

The present invention relates to a formulation optimized for a fusion protein dimer that comprises an extracellular domain of an alpha subunit of an IgE Fc receptor and, more specifically, to an aqueous pharmaceutical formulation having a pH of 6.0-7.0, comprising a fusion protein dimer that compris...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KWON, Soontak, CHO, Young-Gyu, JANG, Myung Ho
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a formulation optimized for a fusion protein dimer that comprises an extracellular domain of an alpha subunit of an IgE Fc receptor and, more specifically, to an aqueous pharmaceutical formulation having a pH of 6.0-7.0, comprising a fusion protein dimer that comprises an extracellular domain of an alpha subunit of an IgE Fc receptor, histidine, proline, methionine, and Poloxamer 188. The fusion protein present in the formulation according to the present invention is contained at a high concentration, has improved stability and thus can be easily administered through subcutaneous injection, and has excellent IgE-binding capacity as compared to existing therapeutic agents comprising an anti-IgE antibody, and thus can be usefully utilized in an injection for treating an IgE-mediated allergic disease.